Bleakley Financial Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2,213
| Closed | -$506K | – | 884 |
|
2024
Q4 | $506K | Sell |
2,213
-21
| -0.9% | -$4.8K | 0.02% | 617 |
|
2024
Q3 | $545K | Buy |
2,234
+78
| +4% | +$19K | 0.02% | 582 |
|
2024
Q2 | $413K | Buy |
2,156
+96
| +5% | +$18.4K | 0.01% | 667 |
|
2024
Q1 | $408K | Sell |
2,060
-20
| -1% | -$3.96K | 0.01% | 673 |
|
2023
Q4 | $358K | Buy |
2,080
+625
| +43% | +$108K | 0.01% | 684 |
|
2023
Q3 | $215K | Sell |
1,455
-687
| -32% | -$102K | 0.01% | 784 |
|
2023
Q2 | $468K | Sell |
2,142
-3
| -0.1% | -$655 | 0.01% | 605 |
|
2023
Q1 | $470K | Sell |
2,145
-221
| -9% | -$48.4K | 0.02% | 588 |
|
2022
Q4 | $492K | Buy |
+2,366
| New | +$492K | 0.02% | 561 |
|